Clinical Trials Logo

Propofol Adverse Reaction clinical trials

View clinical trials related to Propofol Adverse Reaction.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05358535 Recruiting - Anesthesia Clinical Trials

Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial)

PEAC
Start date: September 19, 2022
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the hemodynamics and adverse event profile in comparison between two treatment arms, one using an admixture of propofol and etomidate at a ratio by volume of 25%/75% (P2E7), and one using an admixture of propofol and etomidate at a ratio by volume of 75%/25% (P7E2), for anesthesia during endoscopic procedures at the Clements University Hospital (CUH) endoscopy lab (Endo).

NCT ID: NCT05046054 Recruiting - Pain Clinical Trials

The Effect of Transcutaneous Electrical Nerve Stimulation on Pain During Propofol Injection

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

Propofol, an intravenous sedative agent, frequently produces pain during injection. This study was designed to investigate whether transcutaneous electrical nerve stimulation could reduce pain during propofol injection. in minimizing propofol injection pain.

NCT ID: NCT04727034 Recruiting - Gastric Cancer Clinical Trials

Efficacy and Safety of Remimazolam Tosylate for Sedation in Gastroscopy

Start date: March 2, 2021
Phase: N/A
Study type: Interventional

Propofol is the most commonly used intravenous anesthetic for painless gastroscopy, but propofol significantly inhibits the respiratory and circulatory systems. Therefore, the incidence of intraoperative hypoxemia and hypotension is high. Remazolam tosylate is an ultra-short-acting benzodiazepine drug, which has a mild inhibitory effect on the respiratory and circulatory systems and has anterograde amnesia. These advantages make remazolam tosylate very likely to replace propofol in painless gastroscopic anesthesia.